Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...
Hosted on MSN10mon
Why This Mid Cap Pharma Stock Is Falling After Letter From U.S. FDAShares of Natco Pharma were down on Tuesday after the United States Food and Drug Administration (USFDA) issued a warning letter to the firm about manufacturing violations at one of its facilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback